Sort
23,748 grants matching “melanoma”
A Novel Vaccine Adjuvant KOR-selective Small Molecule Agonist
$190,490Zhaoyang You · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · AI
The Role of Beta-catenin Signaling in Malignant Melanoma
$190,441Marcus W Bosenberg · Yale University · R01 · FY2008 · CA
Genome-wide analysis of UV damage formation, repair, and mutagenesis
$190,432John J Wyrick · Washington State University · R21 · FY2018 · ES
Utah Population Database (UPDB)
$190,414Ken R Smith · University Of Utah · P30 · FY2015 · CA
Using MC1R genotype to impact skin cancer risk behaviors in Hispanics/Latinos
$190,405Peter A Kanetsky · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2019 · CA
PVSRIPO in melanoma
$190,389Georgia Beasley · Duke University · K08 · FY2023 · CA
Pathways from genotype and environment to melanoma
$190,379Nicholas K Hayward · Queensland Institute Of Medical Research · R01 · FY2010 · CA
(PQA1) Molecular Mechanism of Metformin in Cancer
$190,313Chengkai Dai · Jackson Laboratory · R21 · FY2014 · CA
Germline Susceptibility in Double Primary Cancers via Nexy-Generation Sequencing
$190,259Zsofia Kinga Stadler · Sloan-Kettering Inst Can Research · R21 · FY2014 · CA
Developmental Funds
$190,209Louis M Weiner · Georgetown University · P30 · FY2017 · CA
NEISSERIAL PORINS AND ANTIGEN PRESENTING CELL
$190,179Boston Medical Center · R01 · FY2000 · AI
The Role of ADAM9 in the Innate Immune Response to SARS-CoV-2 Infection
$190,058Lindsey E Bazzone · Univ Of Massachusetts Med Sch Worcester · K08 · FY2025 · AI
ASYMMETRIC SYNTHESIS OF ANTITUMOR POLYKETIDES
$190,003University Of North Carolina Chapel Hill · R01 · FY2001 · CA
Characterization of the Immunomic Profile of Head and Neck Cancer
$190,000Nisha J D'silva · University Of Michigan At Ann Arbor · R21 · FY2009 · DE
THE ROLE OF IL-34 IN THE BIOLOGY OF LANGERHANS CELLS
$190,000Marco Colonna · Washington University · R21 · FY2013 · AI
Inhibition of the host cell AIM2 inflammasome by Mycobacterium tuberculosis
$190,000Volker Briken · Univ Of Maryland, College Park · R21 · FY2015 · AI
"Combining radiation with TLR5 agonist based immunotherapy against liver metastases"
$189,986Andrei V Gudkov · Roswell Park Cancer Institute Corp · R21 · FY2020 · CA
Patient-oriented research and mentoring program in dermatologic diseases
$189,937Maryam Mandana Asgari · Massachusetts General Hospital · K24 · FY2017 · AR
MODULATION OF NF-kB ACTIVATION BY A NOVEL MITOCHONDRIAL E3 UBIQUITIN LIGASE
$189,900Claudio A.p. Joazeiro · Scripps Research Institute, The · R01 · FY2009 · GM
Immune Mechanisms in Choroidal Neovascularization
$189,758Rajendra S Apte · Washington University · K08 · FY2006 · EY
Discovery of PD-1/PDL-1 inhibitors from marine microbial natural products
$189,600William Fenical · University Of California, San Diego · R01 · FY2021 · CA
A High-Throughput Model for Human Melanoma
$189,600Sheri L. Holmen · Nevada Cancer Institute · R01 · FY2008 · CA
A High-Throughput Model for Human Melanoma
$189,600Sheri L. Holmen · Nevada Cancer Institute · R01 · FY2009 · CA
WNT GENES AND SIGNALING IN XENOPUS
$189,594University Of Washington · R01 · FY2003 · HD
mTOR-dependent pathways in skin carcinogenesis
$189,582Lisa M Shantz · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2011 · ES